FDA Inspection 1161608 — Bioradius Therapeutic Research Pvt. Ltd.
The FDA completed an inspection of Bioradius Therapeutic Research Pvt. Ltd. on Jan 14, 2022 in Pune. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 14, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pune (India)
Additional Details
Clinical BA/BE